StockData
Abbott Laboratories logo

Abbott Laboratories

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$110.16+3.96 (+3.73%)

Close on Nov 2, 2026Market cap $190.62BP/E 35.4Yield 2.18%

Abbott Laboratories Core Laboratory Diagnostics by Year

Core Laboratory Diagnostics (Alinity ci/i/c/m/h/s, ARCHITECT, GLP Track) — Organic / Comparable Sales Growth (%) (%)

Abbott Laboratories Core Laboratory Diagnostics: 2.1% in FY2025, down 3.5 pts from a year earlier.

Latest, FY2025
2.1%
Period ended Dec 31, 2025
Change on a year earlier
-3.5 pts
5.6% in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below

Where the FY2025 figure comes from

“|| Sales 12M25 ($ in millions) | Total | Core Laboratory | Molecular | Point of Care | Rapid Diagnostics || Organic | (4.5) | 2.1 | (1.2) | 3.1 | (18.0)”

Source: SEC Filing (0001628280-26-002982) ↗

Reported in Form 8-K Quarterly Earnings Releases (Item 2.02 Revenue Tables) & Form 10-K/10-Q MD&A.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCore Laboratory Diagnostics (Alinity ci/i/c/m/h/s, ARCHITECT, GLP Track) — Organic / Comparable Sales Growth (%) (%)Year on yearSource
FY2025Dec 31, 20252.1%-3.5 ptsSEC Filing (0001628280-26-002982) ↗
FY2024Dec 31, 20245.6%-2.8 ptsSEC Filing (0001628280-25-002092) ↗
FY2023Dec 31, 20238.4%+6.5 ptsSEC Filing (0001628280-24-002009) ↗
FY2022Dec 31, 20221.9%-10.5 ptsSEC Filing (0001628280-23-001516) ↗
FY2021Dec 31, 202112.4%+15.2 ptsSEC Filing (0001104659-22-007648) ↗
FY2020Dec 31, 2020-2.8%-12.8 ptsSEC Filing (0001104659-21-007942) ↗
FY2019Dec 31, 201910.0%+2.0 ptsSEC Filing (0001104659-20-005717) ↗
FY2018Dec 31, 20188.0%+2.1 ptsSEC Filing (0001104659-19-002848) ↗
FY2017Dec 31, 20175.9%0.0 ptsSEC Filing (0001104659-18-003691) ↗
FY2016Dec 31, 20165.9%+8.7 ptsSEC Filing (0001104659-17-003920) ↗
FY2015Dec 31, 2015-2.8%–SEC Filing (0001104659-16-091861) ↗

Cite this data

StockData. (2026). Abbott Laboratories Core Laboratory Diagnostics (%), annual FY2015–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/dx-cl-yoy-org

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.